We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
Change your protocol, update your authorisation, report safety issues, submit safety updates and complete your end-of-trial study report.
When military end-use export controls apply and to which destinations.
The VDEC clinical evaluation team works to support vaccine and therapeutic development by providing expertise in immunological and functional assays used to support clinical trials (Phase I to IV)
How to claim R&D expenditure credit (RDEC) for Corporation Tax relief on your company's R&D, if you’re a large company or small and medium-sized enterprise.
This guidance explains what rules of origin (RoOs) are and the changes under the Developing Countries Trading Scheme (DCTS).
Guidance on Conditional Marketing Authorisations, exceptional circumstances Marketing Authorisations and national scientific advice
The Vaccine Development Evaluation Centre (VDEC) at Porton Down in Wiltshire facilitates the development and evaluation of new vaccines and therapeutics.
This guidance provides an overview of the different tariffs for products exported to the UK under the DCTS, including how to identify commodity codes.
Guidance on choosing evaluation study types and methods.
Sets out special provisions for Crown development for dealing with security-sensitive information in planning applications.
Directory of current ICH Guidelines which have been implemented by the Medicines and Healthcare products Regulatory Agency.
How to use an N-of-1 study to evaluate your digital health product.
How to use a contextual inquiry when developing your digital health product.
How to use a randomised controlled trial to evaluate your digital health product.
How end-use controls apply to weapons of mass destruction (WMD) related goods, software, technology and technical assistance.
How to use a multiphase optimisation strategy (MOST) to evaluate your digital health product.
What detailed information you need to send to HMRC to support your Research and Development (R&D) tax relief claim, and when and how to submit it.
The process for applicants applying for a Paediatric Investigation Plan (PIP) modification or waiver.
The guide, toolkit and further information for GB authorities with responsibility for consumer product safety.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).